A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Clinical trial NCT04443751 · COMPLETED
Trial details
- NCT number
- NCT04443751
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2023-02-28
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.